|
全民健康保險藥品給付規定 / 健保碼及健保價 |
|
See related Mikelan LA Ophthalmic ophth soln[大塚美特朗 持續性點眼液] information |
|
|
|
製造商 |
Otsuka |
|
代理/經銷商 |
Otsuka |
|
成份 |
Carteolol HCl
Click to view carteolol information |
|
適應症及用量 |
For details on therapeutic uses and relevant dosage relating to the carteolol ... Click to view carteolol |
|
美國食品藥物管理局之懷孕等級 |
Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus.
Category D: There is positive evidence of human foetal risk, but the benefits from use in pregnant women may be acceptable despite the risk (e.g., if the drug is needed in a life-threatening situation or for a serious disease for which safer drugs cannot be used or are ineffective). |
|
劑型/包裝 |
|
劑型 |
包裝 |
圖片 |
|
Mikelan LA Ophthalmic 眼用液劑 |
|
Mikelan LA Ophthalmic 1 % x 2.5 mL |
|
Mikelan LA Ophthalmic 2 % x 2.5 mL |
|
|
|
Manufacturer: |
Otsuka |
|
Distributor: |
Otsuka
|
|
|
|
